510(k) Report

510(k) · Cleared

Cleared

Carto RMT EP Navigation System V8

K060047510(k) TraditionalCleared Jun 19, 2006164-day reviewClass II21 CFR 870.1220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biosense Webster, Inc. · DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

Cleared on Jun 19, 2006 after a 164-day review. The FDA summary names its predicate without a number. 49 later devices descend from it.

Decided
Jun 19, 2006
Review
164 days
Class
Class II
Product code
DRF
Recalls
None
Predicates
0

49 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2009: 3 descendants cleared2013: 1 descendant cleared2010: 1 descendant cleared2011: 2 descendants cleared2020: 2 descendants cleared2014: 2 descendants cleared2017: 2 descendants cleared2018: 5 descendants cleared2024: 4 descendants cleared2022: 3 descendants cleared2023: 5 descendants cleared2025: 7 descendants cleared2021: 2 descendants cleared2012: 1 descendant cleared2019: 2 descendants cleared2016: 1 descendant cleared2026: 5 descendants cleared20052010201520202025
  1. This deviceK060047 Carto RMT EP Navigation System V8Biosense Webster, Inc. · 2006
  2. Descendant · cites it directly · 47 of its ownK072202 Carto 3 Navigation System (Model:FG-5400-00), Carto 3 External…Biosense Webster, Inc. · 2007
  3. Descendant · cites it directly · 45 of its ownK090017 Carto 3 EP Navigation System, V1.0 and AccessoriesBiosense Webster, Inc. · 2009 · Recalled
  4. Descendant · 2 generations on · 34 of its ownK093455 Carto 3 Version 1.05 EP Navigation System and AccessoriesBiosense Webster, Inc. · 2009 · Recalled
  5. Descendant · 3 generations on · 33 of its ownK103746 Carto 3 EP Navigation System, Version 2.0 (W/Standard Location…Biosense Webster, Inc. · 2011 · Recalled
  6. Descendant · 4 generations on · 32 of its ownK112007 Carto 3 EP Navigation System, Version 2.2Biosense Webster, Inc. · 2011 · Recalled

Showing 5 of 49 descendants. See all descendants

Descendants cleared per year

2007: 12009: 32010: 12011: 22012: 12013: 12014: 22016: 12017: 22018: 52019: 22020: 22021: 22022: 32023: 52024: 42025: 72026: 5
2007high 7 (2025) · low 0 (2008)2026

Most influential descendants

Showing 5 of 49 · See all
  • K072202Carto 3 Navigation System (Model:FG-5400-00), Carto 3 External Reference Patches…Biosense Webster, Inc. · 2007 · cites it directly47descendants
  • K090017Carto 3 EP Navigation System, V1.0 and AccessoriesBiosense Webster, Inc. · 2009 · cites it directly45descendants
  • K093455Carto 3 Version 1.05 EP Navigation System and AccessoriesBiosense Webster, Inc. · 2009 · 2 generations on34descendants
  • K103746Carto 3 EP Navigation System, Version 2.0 (W/Standard Location Pad),CARTO3 Epnavigation…Biosense Webster, Inc. · 2011 · 3 generations on33descendants
  • K112007Carto 3 EP Navigation System, Version 2.2Biosense Webster, Inc. · 2011 · 4 generations on32descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K060047Carto RMT EP Navigation System V8Biosense Webster, Inc.2006—
+1K072202Carto 3 Navigation System (Model:FG-5400-00), Carto 3 External Reference…Biosense Webster, Inc.2007—
+1K090017Carto 3 EP Navigation System, V1.0 and AccessoriesBiosense Webster, Inc.20094
+2K093455Carto 3 Version 1.05 EP Navigation System and AccessoriesBiosense Webster, Inc.20091
+3K103746Carto 3 EP Navigation System, Version 2.0 (W/Standard Location Pad),CARTO3…Biosense Webster, Inc.20111
+4K112007Carto 3 EP Navigation System, Version 2.2Biosense Webster, Inc.20112

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200930
201010
201120
201210
201310
201420
201610
201720
201850
201920
202020
202120
202230
202350
202440
202570
202650
FIG. 1 — Lineage of K060047, 2006–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DRF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DRF device

  1. #1 K252794 Vision-MR™ Diagnostic Catheterscore 13.7 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—CARTO™ XP EP Navigation System v8
Named without a submission number
—
*—CARTO™ RMT EP Navigation System v7
Named without a submission number
—

What descends from it? (49)

See all 49

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K072202Carto 3 Navigation System (Model:FG-5400-00), Carto 3 External Reference Patches…Biosense Webster, Inc.200747
K090017Carto 3 EP Navigation System, V1.0 and AccessoriesBiosense Webster, Inc.200945
K091789Carto RMT EP Navigation System V8Biosense Webster, Inc.20090

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K072202 (Biosense Webster, Inc., 2007) has gone furthest, with 47 descendants of its own.

How does its category compare?

All DRF devices

DRF Catheter, Electrode Recording, Or Probe, Electrode Recording: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DRF

3in 2025

2007: 22008: 22009: 72010: 52011: 32012: 12013: 22014: 12015: 32016: 82017: 72018: 12019: 102020: 42021: 122022: 82023: 52024: 42025: 32026 (partial year): 2
2007high 12 (2021) · low 1 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DRF

45in 2023

2009: 243 days median2010: 65 days median2011: 190 days median2015: 29 days median2016: 175 days median2019: 163 days median2021: 124 days median2022: 283 days median2023: 45 days median
2007high 283 (2022) · low 29 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DRF

1in 2015

2007: 22008: 42011: 62014: 22015: 1
2007high 6 (2011) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DRF

508in 2025

2007: 1202008: 1762009: 1222010: 1302011: 2452012: 4022013: 3102014: 3492015: 3272016: 3832017: 4582018: 7232019: 6692020: 6512021: 6252022: 6132023: 6852024: 6232025: 508
2007high 723 (2018) · low 120 (2007)2025

MAUDE reports naming product code DRF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—2120
20082—4176
200972430122
20105650130
201131906245
20121—0402
20132—0310
20141—2349
20153291327
201681750383
20177—0458
20181—0723
2019101630669
20204—0651
2021121240625
202282830613
20235450685
20244—0623
20253—0508
20262—0—

What is it indicated for?

The intended use of the CARTO™ RMT EP Navigation System v8 is catheter-based atrial and ventricular mapping. The CARTO RMT System v8 allows real-time display of cardiac maps in a number of different formats. Maps may be displayed as cardiac electrical activation maps, cardiac electrical propagation maps, cardiac electrical potential maps, impedance maps, and cardiac chamber geometry maps. The acquired patient signals, including body surface ECG and…

Read the full statement (210 words)

The intended use of the CARTO™ RMT EP Navigation System v8 is catheter-based atrial and ventricular mapping.

The CARTO RMT System v8 allows real-time display of cardiac maps in a number of different formats. Maps may be displayed as cardiac electrical activation maps, cardiac electrical propagation maps, cardiac electrical potential maps, impedance maps, and cardiac chamber geometry maps. The acquired patient signals, including body surface ECG and intracardiac electrograms may also be displayed in real time on the display screen.

The CARTO RMT System v8 is intended to support EP procedures in the presence of the high metallic environment presented by the NIOBE I (PM3.0) and Niobe 2 (PM3.1 and PM3.2) Stereotaxis Magnetic Navigation Systems (MNS) in magnetic environments of up to 0.08 Tesla.

Although the CARTO™ RMT system requires the use of a magnetic steerable catheter, i.e. the NAVISTAR RMT, when used in conjunction with the Stereotaxis Niobe MNS, it also enables the use of the standard NAVISTAR and QWIKSTAR catheters when the Stereotaxis magnets are stowed away or when used in a conventional EP lab, maintaining full CARTO™ XP capabilities.

CARTO RMT System v8 includes the CARTOMERGE™ capability to import, register and merge CT or MRI structural images with CARTO maps physiological information and real time catheter navigation.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060047: Carto RMT EP Navigation System V8.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K060047

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026